ASSOCIATION OF CYP2B6 G516T POLYMORPHISM WITH THE SUSCEPTIBILITY OF de novo ACUTE MYELOGENOUS LEUKEMIA

被引：0
|
作者：
Daraki, A. [1 ]
Zachaki, S. [1 ]
Koromila, T. [2 ]
Karakosta, M. [1 ]
Pantelias, G. [1 ]
Aleporou, V. [2 ]
Sambani, C. [1 ]
Kollia, P. [2 ]
Manola, K. [1 ]
机构：
[1] NCSR Demokritos, Athens, Greece
[2] Natl & Kapodistrian Univ, Fac Biol, Athens, Greece
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0639
引用
收藏
页码：262 / 262
页数：1
相关论文
共 50 条
  • [1] THE G516T POLYMORPHISM OF CYP2B6 GENE AS A POSSIBLE PREDISPOSING FACTOR FOR THE DEVELOPMENT OF ACUTE MYELOID LEUKEMIA
    Daraki, A.
    Zachaki, S.
    Koromila, T.
    Pantelias, G.
    Aleporou, V.
    Sambani, C.
    Kollia, P.
    Manola, K. N.
    [J]. ANNALS OF HEMATOLOGY, 2013, 92 : S2 - S2
  • [2] Association of CYP2B6 G15631T polymorphism with acute leukemia susceptibility
    Berkoz, Mehmet
    Yalin, Serap
    [J]. LEUKEMIA RESEARCH, 2009, 33 (07) : 919 - 923
  • [3] The G516T CYP2B6 Germline Polymorphism Affects the Risk of Acute Myeloid Leukemia and Is Associated with Specific Chromosomal Abnormalities
    Daraki, Aggeliki
    Zachaki, Sophia
    Koromila, Theodora
    Diamantopoulou, Paraskevi
    Pantelias, Gabriel E.
    Sambani, Constantina
    Aleporou, Vasiliki
    Kollia, Panagoula
    Manola, Kalliopi N.
    [J]. PLOS ONE, 2014, 9 (02):
  • [4] The Clinical Spectrum and G516T CYP2B6 Single Nucleotide Polymorphism in Efavirenz Drug Induced Liver Injury
    Sonderup, Mark W.
    Abdullah, Gadija
    Davidson, Brandon
    Maughan, Deborah
    Gogela, Neliswa
    Spearman, Catherine Wendy
    [J]. HEPATOLOGY, 2018, 68 : 210A - 210A
  • [5] Pharmacogenetic screening: HLA-B*5701 vs. CYP2B6 G516T
    Lin, A. W. C.
    Yam, W-C
    Lam, H-Y
    To, S.
    Chan, D.
    Chan, K. C. W.
    Lee, S-S
    [J]. HIV MEDICINE, 2011, 12 (04) : 255 - 256
  • [6] The implications of a high allelic frequency of CYP2B6 G516T in ethnic Chinese persons
    Tong, Kenneth
    He, Ming-Liang
    Lin, Che-Kit
    Guo, Liping
    Kung, Hsiang-Fu
    Sung, Joseph J. Y.
    Lee, Shui-Shan
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (04) : 541 - 542
  • [7] The clinical spectrum and G516T CYP2B6 single-nucleotide polymorphism in efavirenz drug-induced liver injury
    Sonderup, Mark
    Abdullah, Gadija
    Gogela, Neliswa
    Spearman, C. Wendy
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2018, 108 (08): : 692 - 692
  • [8] GENETIC VARIABILITY OF CYP2B6 G516T AND THEIR IMPACT IN EFAVIRENZ BASED HAART: A META-ANALYSIS
    Mulugeta, Anwar
    Eyakim, Abiy H.
    Belew, Yewbdar
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (03): : 763 - 772
  • [9] CYP2B6 G516T genotyping in a UK cohort of HIV-positive patients: polymorphism frequency and influence on efavirenz discontinuation
    Powers, V.
    Ward, J.
    Gompels, M.
    [J]. HIV MEDICINE, 2009, 10 (08) : 520 - 523
  • [10] Distribution of CYP2B6 516G/T pharmacogenetically important polymorphism in the Ukrainian population
    Filiptsova, Olga
    Kobets, Marina
    Kobets, Julia
    Naboka, Olga
    Koiro, Olga
    Ochkur, Alexandr
    Galiy, Larisa
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2018, 26 (05) : 651 - 655
12345